Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Baculima Barreto, Dania Marisol"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Revisión bibliográfica de los efectos de los suplementos probióticos sobre los parámetros bioquímicos relacionados con la glucosa y los lípidos en pacientes con diabetes mellitus tipo 2
    (Universidad de Cuenca, 2022-10-12) Chumbi Landy, María José; Baculima Barreto, Dania Marisol; Ochoa Castro, Maritza Raphaela
    DM2 is an endocrine-metabolic disease characterized by chronic hyperglycemia. Probiotics have become a novel therapeutic modality for the control and/or prevention of DM2 through the modulation of the intestinal microbiota. The objective of this review was to determine the effect of probiotic supplements on biochemical parameters of glucose and lipids in patients with DM2 through a literature review. The databases used are PubMed, ScienceDirect, and Scopus to search for clinical trials that have examined the effects of probiotic supplementation on basal glucose parameters, HbA1c, basal insulin, HOMA-IR index, TC, TG, C -HDL, and LDL-C in patients with DM2. The quality of the selected articles was evaluated using the “PEDRO” scale. The results of this review indicate that most part of the scientific evidence reports a significant decrease until -37.16 mg/dl of basal glucose, - 0.65% HbA1c, and - 24.36 mg/dl of TC after the intake of probiotics, especially of the genera Lactobacillus and bifidobacterium. There are not enough clinical trials that report positive changes in TG and HDL-C, in addition, the changes in basal insulin concentrations, HOMAIR index, and LDL-C are not entirely conclusive. Our review suggests that taking probiotics is beneficial and could be a complementary therapeutic approach in patients with DM2.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback